BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
CXCL2
,
Response to oxidative stress
,
Breast Cancer
,
Prostate
,
Cisplatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cardiac allograft vasculopathy
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for cardiac allograft vasculopathy
Explore Curated Studies Results
Literature
Most Relevant Literature
mTor-inhibition within the first days after pediatric heart transplantation is a potentially safe op…
Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation.
Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for …
Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differe…
Prevention of cardiac allograft vasculopathy - A new possible indication for SGLT-2 inhibitors?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Tran…
Microvascular Cardiac Allograft Vasculopathy Trial
Assessment of Cardiac Allograft Vasculopathy by Optical Coherence Tomography
Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ